480439-26-7

Basic information

• Product Name: 4-SEC-BUTYLPHENYL ISOCYANATE 97
• Synonyms: 4-SEC-BUTYLPHENYL ISOCYANATE 97;1-sec-butyl-4-isocyanatobenzene(SALTDATA: FREE);1-butan-2-yl-4-isocyanatobenzene
• CAS NO: 480439-26-7
• Molecular Formula: C11H13NO
• Molecular Weight: 175.23
• Product Categories: Isocyanates;Nitrogen Compounds;Organic Building Blocks
• Mol File: 480439-26-7.mol

Chemical Properties

• Boiling Point: 199-200 °C(lit.)
• Flash Point: 175 °F
• Appearance: /
• Density: 0.988 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.0491mmHg at 25°C
• Refractive Index: n20/D 1.5170(lit.)
• CAS DataBase Reference: 4-SEC-BUTYLPHENYL ISOCYANATE 97(CAS DataBase Reference)
• NIST Chemistry Reference: 4-SEC-BUTYLPHENYL ISOCYANATE 97(480439-26-7)
• EPA Substance Registry System: 4-SEC-BUTYLPHENYL ISOCYANATE 97(480439-26-7)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 480439-26-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H13NO/c1-3-9(2)10-4-6-11(7-5-10)12-8-13/h4-7,9H,3H2,1-2H3

Upstream product

• 32315-10-9 bis(trichloromethyl) carbonate 
• 30273-11-1 4-sec-butylaniline 

Downstream Products

• 1563536-51-5 N¹-(4-(sec-butyl)phenyl)-N²-(pyridin-2-ylmethyl)diazene-1,2-dicarboxamide 
• 1563536-45-7 ethyl 2-((4-(sec-butyl)phenyl)carbamoyl)diazenecarboxylate 
• 1563536-62-8 N¹-(4-(sec-butyl)phenyl)-N²-(pyridin-4-ylmethyl)diazene-1,2-dicarboxamide 
• 900085-87-2 ethyl 2-((4-(sec-butyl)phenyl)carbamoyl)hydrazinecarboxylate 

Relevant articles and documents

Diazenedicarboxamides as inhibitors of D-alanine: D-alanine ligase (Ddl)

This invention belongs to the field of pharmaceutical chemistry and relates to new diazenedicarboxamides as inhibitors of D-alanine:D-alanine ligaze (Ddl), to procedures for their preparation and pharmaceutical preparations containing the same. Compounds of general formula I: and the pharmaceutically acceptable salts are described. The appropriate substituents are clearly presented in the body of the text and in claims.